China
China's healthcare sector set for global breakout
China's healthcare sector set for global breakout
Greater China completed 186 cross-border biotech out-licensing deals in 2025.
6 hours ago
China healthcare lags Hong Kong and global markets in 2026
It posted the largest decline in price-to-earnings.
2 days ago
A+H dual listings signal China healthcare’s shift toward global expansion
Hong Kong serves as a key platform for global capital access.
China healthcare sector hit by regulation, biotech uncertainty
The sector stayed Overweight, supported by innovation and global deal activity.
China pushes expanded national maternity insurance systems in draft law
Several regions have already expanded coverage to flexible workers.
China’s healthcare index sinks 7.1% as investors pivot to tech AI
The sector’s stocks lag as AI inflows reshaped sector allocation patterns.
China healthcare firms offset policy pressure with global growth
Most major healthcare companies reported satisfactory 2025 financial results.
China Biopharma’s $56.7b deal boom signals pillar industry dominance
Out-licensing jumped 132% as sector becomes second-largest global hub.
Ping An Good Doctor projected to see 56% profit CAGR surge by 2027
Ali Health adjusted net profit forecast at 24% CAGR.
China captures 49% of global drug deals in 2025 amidst lower costs, faster timelines
This is an improvement from only 6% in 2020.
Strong pipeline, M&A activity could trigger rapid earnings for Greater China's healthcare firms: UOB
The industry is expected to become a key international player.
China commands 30% of global biopharma pipeline; drives Asia’s share to 43%
The country transitions from fast follower to global innovation frontrunner.
Greater China healthcare keeps 'overweight' rating as R&D, biotech drive expansion
Outlook still positive despite trade and regulatory risks.
TAC-302 therapy seizes bladder cure market lead in China
This comes as the population ages and chronic conditions rise.
Perennial Holdings launches Healthcare City in Chongqing, China
Its first phase involves a total investment of approximately $212.8m (RMB1.5b).
China medical device market grows at 8.1% CAGR through 2029
High costs remain a challenge despite expanding digital adoption.
Two Shanghai hospitals sign MoU to strengthen clinical collaboration
The partnership follows the recent opening of Parkway MediCentre Xintiandi.
Most Read
1. Singapore’s AI tool analyses heart attack damage within one minute 2. APAC turns to AI as healthcare worker shortfall nears 11 million 3. How can Asia-Pacific prove medical research is worth the money? 4. HKUMed pioneers robot-assisted living-donor liver transplant 5. Medical Taiwan 2026 closes with $168.7m in business opportunitiesResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention